Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Rhythm Pharmaceuticals, Inc. (RYTM) had Free Cash Flow per Share of $-0.64 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$32.70M |
|
$-50.82M |
|
$3.65M |
|
$29.06M |
|
$79.71M |
|
$-47.00M |
|
$-2.41M |
|
$-49.42M |
|
$-49.42M |
|
$-49.50M |
|
$-49.50M |
|
$-49.50M |
|
$-49.50M |
|
$-47.00M |
|
$-46.62M |
|
63.06M |
|
63.06M |
|
$-0.81 |
|
$-0.81 |
|
| Balance Sheet Financials | |
$369.29M |
|
$0.46M |
|
$17.40M |
|
$386.69M |
|
$111.82M |
|
-- |
|
$111.77M |
|
$223.60M |
|
$18.95M |
|
$157.13M |
|
$163.09M |
|
63.49M |
|
| Cash Flow Statement Financials | |
$-40.35M |
|
$24.81M |
|
$32.50M |
|
$89.60M |
|
$106.56M |
|
$16.96M |
|
$12.86M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.30 |
|
-- |
|
-- |
|
-- |
|
-- |
|
88.85% |
|
-143.73% |
|
-143.73% |
|
-- |
|
-151.11% |
|
-155.39% |
|
$-40.35M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.19 |
|
1.83 |
|
49.05 |
|
-261.25% |
|
-31.50% |
|
-12.80% |
|
-30.35% |
|
$2.57 |
|
|
Free Cash Flow per Share |
$-0.64 |
$-0.64 |
|